Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significance

The endocannabinoid system (ECS) comprises cannabinoid receptors (CBs), endogenous cannabinoids, and enzymes responsible for their synthesis, transport, and degradation of (endo)cannabinoids. To date, two CBs, CB1 and CB2, have been characterized; however, orphan G-protein-coupled receptor GPR55 has...

Full description

Saved in:
Bibliographic Details
Published in:OncoTargets and therapy 2016-01, Vol.9, p.4323-4336
Main Authors: Pyszniak, Maria, Tabarkiewicz, Jacek, Łuszczki, Jarogniew J
Format: Article
Language:English
Subjects:
Apoptosis
Cancer therapies
Cancer treatment
Cannabinoid CB1 receptors
Cannabinoids
Carcinogenesis
Cell receptors
Cellular signal transduction
Clinical significance
Cytokines
Endocannabinoid system
Endocannabinoids
Enzymes
Fatty acids
Forecasts and trends
Gene expression
Genetic aspects
Health aspects
Medical prognosis
Medicine
Prostate cancer
Review
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The endocannabinoid system (ECS) comprises cannabinoid receptors (CBs), endogenous cannabinoids, and enzymes responsible for their synthesis, transport, and degradation of (endo)cannabinoids. To date, two CBs, CB1 and CB2, have been characterized; however, orphan G-protein-coupled receptor GPR55 has been suggested to be the third putative CB. Several different types of cancer present abnormal expression of CBs, as well as other components of ECS, and this has been shown to correlate with the clinical outcome. Although most effects of (endo)cannabinoids are mediated through stimulation of classical CBs, they also interact with several molecules, either prosurvival or proapoptotic molecules. It should be noted that the mode of action of exogenous cannabinoids differs significantly from that of endocannabinoid and results from the studies on their activity both in vivo and in vitro could not be easily compared. This review highlights the main signaling pathways involved in the antitumor activity of cannabinoids and the influence of their activation on cancer cell biology. We also discuss changes in the expression pattern of the ECS in various cancer types that have an impact on disease progression and patient survival. A growing amount of experimental data imply possible exploitation of cannabinoids in cancer therapy.
ISSN:1178-6930
1178-6930
DOI:10.2147/OTT.S106944